21 related articles for article (PubMed ID: 21794916)
1. Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Hochhaus A; Saussele S; Rosti G; Mahon FX; Janssen JJWM; Hjorth-Hansen H; Richter J; Buske C;
Ann Oncol; 2017 Jul; 28(suppl_4):iv41-iv51. PubMed ID: 28881915
[No Abstract] [Full Text] [Related]
2. Dasatinib-induced response in a rare case of chronic lymphocytic leukaemia associated with chronic myeloid leukaemia.
Tecchio C; Nichele I; Todeschini G; Pizzolo G; Ambrosetti A
Br J Haematol; 2009 Jul; 146(2):222-3. PubMed ID: 19466973
[No Abstract] [Full Text] [Related]
3. Successful peripheral blood stem cell mobilization with granulocyte colony-stimulating factor in a patient with chronic myeloid leukemia achieving a complete cytogenetic remission with dasatinib after failing imatinib.
Gabriel I; Chaidos A; Sorouri J; Dannie E; Davis J; Goldman J; Apperley J; Marin D
Leukemia; 2008 Aug; 22(8):1618-9. PubMed ID: 18305564
[No Abstract] [Full Text] [Related]
4. Successful second allogeneic stem cell transplantation in second remission induced by dasatinib in a child with Philadelphia chromosome positive acute lymphoblastic leukemia.
Millot F; Cividin M; Brizard F; Chomel JC; Méchinaud F; Guilhot F
Pediatr Blood Cancer; 2009 Jul; 52(7):891-2. PubMed ID: 19202569
[TBL] [Abstract][Full Text] [Related]
5. Regression of cutaneous squamous cell carcinoma in a patient with chronic myeloid leukaemia on imatinib mesylate treatment.
Kawakami Y; Nakamura K; Nishibu A; Yanagihori H; Kimura H; Yamamoto T
Acta Derm Venereol; 2008; 88(2):185-6. PubMed ID: 18311459
[No Abstract] [Full Text] [Related]
6. [Sustained complete molecular remission after cessation of imatinib mesylate treatment in a patient with relapsed chronic myelogenous leukemia after allogeneic stem cell transplantation].
Igarashi T; Hayashi T; Yasui H; Ikeda H; Takahashi T; Ishida T; Shinomura Y
Rinsho Ketsueki; 2012 Feb; 53(2):215-8. PubMed ID: 22450581
[TBL] [Abstract][Full Text] [Related]
7. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
Steinberg M
Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
[TBL] [Abstract][Full Text] [Related]
8. [Predictive factors of successful treatment-free remission for patients with chronic myeloid leukemia].
Takahashi N
Rinsho Ketsueki; 2014 May; 55(5):489-96. PubMed ID: 24881913
[No Abstract] [Full Text] [Related]
9. Dasatinib-induced rapid regression and complete molecular remission of multiple subcutaneous tumours presenting as relapsed chronic myeloid leukaemia after cord blood transplantation.
Nakata J; Okada M; Tamaki H; Satake A; Kaida K; Yoshihara S; Kato R; Ikegame K; Ogawa H
Leuk Res; 2011 Dec; 35(12):1658-9. PubMed ID: 21794916
[No Abstract] [Full Text] [Related]
10. [Chronic myeloid leukemia--treatment].
Stoetzer OJ; Hentrich M; Salat C
Dtsch Med Wochenschr; 2002 Dec; 127(49):2621-4. PubMed ID: 12469275
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
